HopeStage
Back to all studies
CompletedNCT00206960

Brain activity and cognition before and after treatment for first-episode schizophrenia

About this titleRead the official source — NCT00206960

This study assessed thinking abilities.

Medication studyAges 18–45Denmark
The study in practice

Understand this study

What did researchers investigate?

This study assessed thinking abilities.

Who was this study for?

Listed age limits: 18 years to 45 years.

Listed locations
Copenhagen and 5 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 1998
Recruitment status
Completed
Enrollment listed in the registry
56
Sponsor
Birte Glenthoj
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Locations
Denmark
Age range
From 18 Years to 45 Years
Official registry ID
NCT00206960
Official title
Show the full official title

Effects of Classical and Atypical Antipsychotics on Dopamine Receptor Binding of 123I-epidepride, Cognition, Startle Response and Extrapyramidal Side-effects in Drug-naive First-episode Schizophrenic Patients

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Copenhagen · Copenhagen NV · Glostrup Municipality

1 more locations
  • Hvidovre

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

This study assessed thinking abilities.

Who is behind this study?

The study sponsor is Birte Glenthoj.

Did this study involve medication?

Yes. The study involved medication, including zuclopenthixol and risperidone.

Who was this study for?

Listed age limits: 18 years to 45 years.

Want to explore more studies?

Explore studies